Devyser Diagnostics ABFRA:OL0 -2.60%76 Forward Dividend Yield % is 0.00% as of Jun. 28, 2026. GuruFocus rates FRA:OL0 with a GF Score™ of 76/100 and a GF Value™ of €13.58 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 315 Medical Devices & Instruments companies, Devyser Diagnostics AB ranks worse than 317460% on this metric.
As of today (2026-06-28), the Forward Annual Dividend Yield of Devyser Diagnostics AB is 0.00%.
As of today (2026-06-28), the Trailing Annual Dividend Yield of Devyser Diagnostics AB is 0.00%.
FRA:OL0's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.15 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Devyser Diagnostics AB (FRA:OL0) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Devyser Diagnostics AB Forward Dividend Yield % Related Terms
FRA:OL0 vs ABT, SYK, MDT: Forward Dividend Yield % Comparison
For the Medical Devices subindustry, Devyser Diagnostics AB's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Devyser Diagnostics AB Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Devyser Diagnostics AB's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Devyser Diagnostics AB's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Devyser Diagnostics AB (FRA:OL0) has a Forward Dividend Yield % of 0.00% as of Jun. 28, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Devyser Diagnostics AB and its competitors. According to the industry distribution chart, Devyser Diagnostics AB ranks #999999 out of 315 companies in the Medical Devices & Instruments industry.
Is Devyser Diagnostics AB's Forward Dividend Yield % too high?
Devyser Diagnostics AB's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Devyser Diagnostics AB ranks #999999 out of 315 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Devyser Diagnostics AB has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Devyser Diagnostics AB's Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Devyser Diagnostics AB ranks #999999 out of 315 companies for Forward Dividend Yield %. This places Devyser Diagnostics AB in the lower half of its industry. The industry median Forward Dividend Yield % is 2.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.15, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Devyser Diagnostics AB and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Devyser Diagnostics AB's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Devyser Diagnostics AB stock overvalued right now?
Based on GuruFocus' analysis, Devyser Diagnostics AB (FRA:OL0) is currently considered Significantly Undervalued. The stock's GF Value™ is €13.58, compared to a current price of €7.49 — trading 44.8% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Devyser Diagnostics AB's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Devyser Diagnostics AB (FRA:OL0), the current Forward Dividend Yield % is 0.00% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Devyser Diagnostics AB (FRA:OL0) Overvalued in 2026?
Based on GuruFocus' analysis, Devyser Diagnostics AB stock appears to be undervalued.
The current stock price of €7.49 is trading 44.8% below its estimated GF Value™ of €13.58.
GuruFocus considers Devyser Diagnostics AB to be Significantly Undervalued.
Key valuation signals for FRA:OL0:
Forward Dividend Yield %: 0.00%
GF Value™: €13.58 vs. price of €7.49 (44.8% below fair value)
No single metric tells the full story. See the FRA:OL0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Devyser Diagnostics AB is engaged in the development, manufacture, and sale of kits for genetic testing in routine diagnostic laboratories. The products are used for advanced genetic testing in the hereditary disease, oncology, and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.
76GF Score
Get the complete analysis for FRA:OL0
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:OL0 has been successfully added to your 